OpenFilings

AXIM BIOTECHNOLOGIES, INC.

Form8-K

Report Period2023-05-23

Date Filed2023-05-25

Time Filed16:04:19

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
CONSULTING AGREEMENT EFFECTIVE MAY 23, 2023, BY AND BETWEEN THE COMPANY AND ACCA
Filing on SEC Edgar